A Trial to Evaluate the Safety and Efficacy of the Combination of the Oncolytic Immunotherapy Pexa-Vec With the PD-1 Receptor Blocking Antibody Nivolumab in the First-line Treatment of Advanced Hepatocellular Carcinoma (HCC)

Name: A Trial to Evaluate the Safety and Efficacy of the Combination of the Oncolytic Immunotherapy Pexa-Vec With the PD-1 Receptor Blocking Antibody Nivolumab in the First-line Treatment of Advanced Hepatocellular Carcinoma (HCC)
License: Public Domain

Transgene

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

hepatocellular carcinoma (hcc)

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 356478
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.